Integrated analysis of blood donor metabolic phenotypes and genetic traits on red blood cell transfusion effectiveness

• Previously reported blood donor metabolic phenotypes and genetic traits independently impact hemoglobin increments following RBC transfusion • Donor genetic traits also impact downstream RBC transfusion events highlighting the need for refined donor screening to optimize outcomes Recent large-scale population studies in humans and in murine models of red blood cell (RBC) function identified associations between metabolic phenotypes, or genetic traits linked to them, and transfusion effectiveness. These metabolic phenotypes were identified in independent studies focusing on different mechanistic aspects of the storage lesion. The lack of an integrated analysis raised the question as to whether these signatures were redundant measures of the same underlying processes or could be evaluated together to inform a Precision Medicine approach to clinical transfusion practice. To bridge this gap, we performed an integrated analysis in 5,386 patients who received 6,220 single-unit RBC transfusions, evaluating donor metabolic and genetic results from several studies on hemoglobin increments following RBC transfusion. Our results indicate that previously reported metabolic and genetic predictors of hemoglobin increments remain significant, with an effect size between 0.05 and 0.15 g/dL, when evaluated concurrently. Our observational findings indicate that transfusing RBC units from donors with specific genetic traits, are not only negatively associated with immediate effectiveness but also increased downstream RBC transfusion events, further highlighting the need for refined donor screening practices. Altogether, this evidence supports adoption of a Precision Medicine approach to transfusion practice, where genetic screening of donors at first donation and longitudinal metabolic profiling could inform blood inventory management and allocation strategies, ensuring optimal outcomes for transfusion recipients.

Institutions

Publication Details

Journal
Blood Red Cells & Iron
Published
2025-09-27
DOI
https://doi.org/10.1016/j.brci.2025.100030
Citations
1
Primary Topic
Diverse Scientific and Economic Studies
Type
article
Field-Weighted Citation Impact
3.13
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Integrated analysis of blood donor metabolic phenotypes and genetic traits on red blood cell transfusion effectiveness

1 citations
Blood Red Cells & Iron
Diverse Scientific and Economic Studies
3.13
article

Integrated analysis of blood donor metabolic phenotypes and genetic traits on red blood cell transfusion effectiveness

article en
1 citations

Abstract

• Previously reported blood donor metabolic phenotypes and genetic traits independently impact hemoglobin increments following RBC transfusion • Donor genetic traits also impact downstream RBC transfusion events highlighting the need for refined donor screening to optimize outcomes Recent large-scale population studies in humans and in murine models of red blood cell (RBC) function identified associations between metabolic phenotypes, or genetic traits linked to them, and transfusion effectiveness. These metabolic phenotypes were identified in independent studies focusing on different mechanistic aspects of the storage lesion. The lack of an integrated analysis raised the question as to whether these signatures were redundant measures of the same underlying processes or could be evaluated together to inform a Precision Medicine approach to clinical transfusion practice. To bridge this gap, we performed an integrated analysis in 5,386 patients who received 6,220 single-unit RBC transfusions, evaluating donor metabolic and genetic results from several studies on hemoglobin increments following RBC transfusion. Our results indicate that previously reported metabolic and genetic predictors of hemoglobin increments remain significant, with an effect size between 0.05 and 0.15 g/dL, when evaluated concurrently. Our observational findings indicate that transfusing RBC units from donors with specific genetic traits, are not only negatively associated with immediate effectiveness but also increased downstream RBC transfusion events, further highlighting the need for refined donor screening practices. Altogether, this evidence supports adoption of a Precision Medicine approach to transfusion practice, where genetic screening of donors at first donation and longitudinal metabolic profiling could inform blood inventory management and allocation strategies, ensuring optimal outcomes for transfusion recipients.

Blood Red Cells & IronVol. 1(3)
Kaiser Permanente (US), University of British Columbia (CA), RTI International (US), University of California, San Francisco (US), University of Colorado Boulder (US), Pacific Research Institute (US), Vitalant (US), University of Colorado Anschutz Medical Campus (US), University of Colorado Denver (US)
Openalex Percentile: Top 6%
Diverse Scientific and Economic Studies
3.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.